BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12629520)

  • 1. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
    Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
    Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
    Tonin PN; Hudson TJ; Rodier F; Bossolasco M; Lee PD; Novak J; Manderson EN; Provencher D; Mes-Masson AM
    Oncogene; 2001 Oct; 20(45):6617-26. PubMed ID: 11641787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
    Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
    Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
    Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
    Manderson EN; Mes-Masson AM; Novak J; Lee PD; Provencher D; Hudson TJ; Tonin PN
    Genome Res; 2002 Jan; 12(1):112-21. PubMed ID: 11779836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).
    Zietarska M; Maugard CM; Filali-Mouhim A; Alam-Fahmy M; Tonin PN; Provencher DM; Mes-Masson AM
    Mol Carcinog; 2007 Oct; 46(10):872-85. PubMed ID: 17455221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
    Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression between normal and tumor-derived ovarian epithelial cells.
    Ismail RS; Baldwin RL; Fang J; Browning D; Karlan BY; Gasson JC; Chang DD
    Cancer Res; 2000 Dec; 60(23):6744-9. PubMed ID: 11118061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression microarray analysis and genome databases facilitate the characterization of a chromosome 22 derived homogeneously staining region.
    Arcand SL; Mes-Masson AM; Provencher D; Hudson TJ; Tonin PN
    Mol Carcinog; 2004 Sep; 41(1):17-38. PubMed ID: 15352123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Syed V; Zhang X; Lau KM; Cheng R; Mukherjee K; Ho SM
    Oncogene; 2005 Dec; 24(55):8128-43. PubMed ID: 16116479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
    Zorn KK; Jazaeri AA; Awtrey CS; Gardner GJ; Mok SC; Boyd J; Birrer MJ
    Clin Cancer Res; 2003 Oct; 9(13):4811-8. PubMed ID: 14581352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profile differences in high and low metastatic human ovarian cancer cell lines by gene chip.
    Xu S; Mou H; Lü G; Zhu C; Yang Z; Gao Y; Lou H; Liu X; Cheng Y; Yang W
    Chin Med J (Engl); 2002 Jan; 115(1):36-41. PubMed ID: 11930655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of the metastasis-associated genes by gene chip in high metastatic human ovarian cancer cell lines.
    Xu S; Mou H; Gu L; Su D; Zhu C; Liu X
    J Genet Genomics; 2007 Jul; 34(7):581-90. PubMed ID: 17643943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
    Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.